| pubmed-article:17402372 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17402372 | lifeskim:mentions | umls-concept:C0599755 | lld:lifeskim |
| pubmed-article:17402372 | lifeskim:mentions | umls-concept:C0240069 | lld:lifeskim |
| pubmed-article:17402372 | lifeskim:mentions | umls-concept:C0024141 | lld:lifeskim |
| pubmed-article:17402372 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:17402372 | lifeskim:mentions | umls-concept:C1521725 | lld:lifeskim |
| pubmed-article:17402372 | lifeskim:mentions | umls-concept:C0015737 | lld:lifeskim |
| pubmed-article:17402372 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17402372 | pubmed:dateCreated | 2007-4-3 | lld:pubmed |
| pubmed-article:17402372 | pubmed:abstractText | The aim of this study was to describe the clinical manifestations and outcomes of a national cohort of childhood systemic lupus erythematosus (cSLE). All cases of cSLE registered in the Israeli national registry of children with rheumatic diseases between 1987-2003 were examined for disease activity and damage by the SLE disease activity index (SLEDAI) and SLE collaborating clinics/American College of Rheumatology (SLICC/ACR) damage index. Demographic, clinical, laboratory and treatment factors were analysed for their effect on the outcome. One-hundred and two patients were identified, 81% females, with a mean age at diagnosis of 13.3 +/- 2.6 years. The mean SLEDAI score was 17.2 +/- 9.0 (range 2-60). Fifty four patients were followed for at least five years. The mean SLEDAI decreased to 7.6 +/- 6.3 (0-29) and the mean SLICC/ACR damage index was 0.7 +/- 1.6 (0-8). Five patients developed chronic renal failure. No patients died. No factors were found to be significantly associated with the outcome except the initial SLEDAI score. The five-year outcome of our national cSLE cohort was good; with relatively low activity and minimal damage in most patients. The initial SLEDAI predicted the development of late damage. | lld:pubmed |
| pubmed-article:17402372 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17402372 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17402372 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17402372 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17402372 | pubmed:issn | 0961-2033 | lld:pubmed |
| pubmed-article:17402372 | pubmed:author | pubmed-author:HarelLL | lld:pubmed |
| pubmed-article:17402372 | pubmed:author | pubmed-author:RubensteinMM | lld:pubmed |
| pubmed-article:17402372 | pubmed:author | pubmed-author:BrikRR | lld:pubmed |
| pubmed-article:17402372 | pubmed:author | pubmed-author:BerkusVV | lld:pubmed |
| pubmed-article:17402372 | pubmed:author | pubmed-author:NaparstekYY | lld:pubmed |
| pubmed-article:17402372 | pubmed:author | pubmed-author:NavonPP | lld:pubmed |
| pubmed-article:17402372 | pubmed:author | pubmed-author:MevorachDD | lld:pubmed |
| pubmed-article:17402372 | pubmed:author | pubmed-author:BarashJJ | lld:pubmed |
| pubmed-article:17402372 | pubmed:author | pubmed-author:PadehSS | lld:pubmed |
| pubmed-article:17402372 | pubmed:author | pubmed-author:MukamelMM | lld:pubmed |
| pubmed-article:17402372 | pubmed:author | pubmed-author:UzielYY | lld:pubmed |
| pubmed-article:17402372 | pubmed:author | pubmed-author:PressJJ | lld:pubmed |
| pubmed-article:17402372 | pubmed:author | pubmed-author:TauberTT | lld:pubmed |
| pubmed-article:17402372 | pubmed:author | pubmed-author:HashkesP JPJ | lld:pubmed |
| pubmed-article:17402372 | pubmed:author | pubmed-author:GorodnitskiNN | lld:pubmed |
| pubmed-article:17402372 | pubmed:author | pubmed-author:Pediatric... | lld:pubmed |
| pubmed-article:17402372 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17402372 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:17402372 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17402372 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17402372 | pubmed:pagination | 142-6 | lld:pubmed |
| pubmed-article:17402372 | pubmed:meshHeading | pubmed-meshheading:17402372... | lld:pubmed |
| pubmed-article:17402372 | pubmed:meshHeading | pubmed-meshheading:17402372... | lld:pubmed |
| pubmed-article:17402372 | pubmed:meshHeading | pubmed-meshheading:17402372... | lld:pubmed |
| pubmed-article:17402372 | pubmed:meshHeading | pubmed-meshheading:17402372... | lld:pubmed |
| pubmed-article:17402372 | pubmed:meshHeading | pubmed-meshheading:17402372... | lld:pubmed |
| pubmed-article:17402372 | pubmed:meshHeading | pubmed-meshheading:17402372... | lld:pubmed |
| pubmed-article:17402372 | pubmed:meshHeading | pubmed-meshheading:17402372... | lld:pubmed |
| pubmed-article:17402372 | pubmed:meshHeading | pubmed-meshheading:17402372... | lld:pubmed |
| pubmed-article:17402372 | pubmed:meshHeading | pubmed-meshheading:17402372... | lld:pubmed |
| pubmed-article:17402372 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17402372 | pubmed:articleTitle | Outcome of a national Israeli cohort of pediatric systemic lupus erythematosus. | lld:pubmed |
| pubmed-article:17402372 | pubmed:affiliation | Department of Pediatrics, Meir Medical Center, Tel Aviv University Kfar-Saba, Isreal. uziely@zahav.net.il | lld:pubmed |
| pubmed-article:17402372 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17402372 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
